Story perspectives

Breakthrough Study Reveals Evolution of Type V CRISPR Systems

10/2/2025

Summary

Researchers Expand CRISPR

RNA-splitting events transformed transposons into Type V CRISPR-Cas systems (CRISPR-associated proteins), expanding editing.
Researchers identified 146 relatives of TnpB and six TranCs that use CRISPR RNAs and ancestral RNA.
The study notes the evolutionary significance of Type V systems for diagnostics and therapeutics.
In metabolic engineering, efforts target Escherichia coli for hydrogen production from lignocellulose; models aim to boost efficiency.

Summary

CityUHK Advances Genome Editing

City University of Hong Kong (CityUHK) secures funding to advance genome editing therapies for liver and cardiovascular diseases over three years.
Led by Professor Zheng Zongli, this project pursues 'one-and-done' cures by correcting mutations.
Using engineered lipid nanoparticles (eLNPs) for precise, safe delivery, the team notes non-human primate preclinical success and seeks pharma partnerships to accelerate PL-100 and PL-200 trials.

1 of 2

Researchers Expand CRISPR

RNA-splitting events transformed transposons into Type V CRISPR-Cas systems (CRISPR-associated proteins), expanding editing.
Researchers identified 146 relatives of TnpB and six TranCs that use CRISPR RNAs and ancestral RNA.
The study notes the evolutionary significance of Type V systems for diagnostics and therapeutics.
In metabolic engineering, efforts target Escherichia coli for hydrogen production from lignocellulose; models aim to boost efficiency.

1 / 2